These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19895635)

  • 1. Selective effects of PPARgamma agonists and antagonists on human pre-adipocyte differentiation.
    Leyvraz C; Suter M; Verdumo C; Calmes JM; Paroz A; Darimont C; Gaillard RC; Pralong FP; Giusti V
    Diabetes Obes Metab; 2010 Mar; 12(3):195-203. PubMed ID: 19895635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of peroxisome proliferator-activated receptor gamma prevents high-fat diet-induced obesity in vivo.
    Nakano R; Kurosaki E; Yoshida S; Yokono M; Shimaya A; Maruyama T; Shibasaki M
    Biochem Pharmacol; 2006 Jun; 72(1):42-52. PubMed ID: 16696951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties.
    Fujimura T; Kimura C; Oe T; Takata Y; Sakuma H; Aramori I; Mutoh S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):863-71. PubMed ID: 16682454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
    Kim KR; Choi HN; Lee HJ; Baek HA; Park HS; Jang KY; Chung MJ; Moon WS
    Oncol Rep; 2007 Oct; 18(4):825-32. PubMed ID: 17786342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium.
    Scoditti E; Massaro M; Carluccio MA; Distante A; Storelli C; De Caterina R
    Cardiovasc Res; 2010 May; 86(2):302-10. PubMed ID: 20032081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
    Morosetti R; Servidei T; Mirabella M; Rutella S; Mangiola A; Maira G; Mastrangelo R; Koeffler HP
    Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo.
    Kershaw EE; Schupp M; Guan HP; Gardner NP; Lazar MA; Flier JS
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1736-45. PubMed ID: 17848638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells.
    Bernardo A; Bianchi D; Magnaghi V; Minghetti L
    J Neuropathol Exp Neurol; 2009 Jul; 68(7):797-808. PubMed ID: 19535992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor gamma and fatty acid transferase expressions.
    Chen Y; Li Y; Wang Y; Wen Y; Sun C
    Metabolism; 2009 Dec; 58(12):1694-702. PubMed ID: 19767038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor gamma ligands stimulate myeloid differentiation and lipogenensis in human leukemia NB4 cells.
    Yasugi E; Horiuchi A; Uemura I; Okuma E; Nakatsu M; Saeki K; Kamisaka Y; Kagechika H; Yasuda K; Yuo A
    Dev Growth Differ; 2006 Apr; 48(3):177-88. PubMed ID: 16573735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor-1 modulates adipocyte differentiation.
    Liang X; Kanjanabuch T; Mao SL; Hao CM; Tang YW; Declerck PJ; Hasty AH; Wasserman DH; Fogo AB; Ma LJ
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E103-E113. PubMed ID: 16144810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oleanolic acid reduces markers of differentiation in 3T3-L1 adipocytes.
    Sung HY; Kang SW; Kim JL; Li J; Lee ES; Gong JH; Han SJ; Kang YH
    Nutr Res; 2010 Dec; 30(12):831-9. PubMed ID: 21147366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor gamma agonists inhibit adipocyte expression of alpha1-acid glycoprotein.
    Castriota G; Thompson GM; Lin Y; Scherer PE; Moller DE; Berger JP
    Cell Biol Int; 2007 Jun; 31(6):586-91. PubMed ID: 17240171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KR-62980: a novel peroxisome proliferator-activated receptor gamma agonist with weak adipogenic effects.
    Kim KR; Lee JH; Kim SJ; Rhee SD; Jung WH; Yang SD; Kim SS; Ahn JH; Cheon HG
    Biochem Pharmacol; 2006 Aug; 72(4):446-54. PubMed ID: 16797489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Ganoderma lucidum extract on adipocyte differentiation and adiponectin gene expression in the murine pre-adipocyte cell line, 3T3-L1.
    Shimojo Y; Kosaka K; Shirasawa T
    Phytother Res; 2011 Feb; 25(2):202-7. PubMed ID: 20632304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
    Díaz-Delfín J; Morales M; Caelles C
    Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor gamma agonist rosiglitazone attenuates oxyhemoglobin-induced Toll-like receptor 4 expression in vascular smooth muscle cells.
    Wu Y; Zhao XD; Zhuang Z; Xue YJ; Cheng HL; Yin HX; Shi JX
    Brain Res; 2010 Mar; 1322():102-8. PubMed ID: 20132800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme.
    Varley CL; Stahlschmidt J; Lee WC; Holder J; Diggle C; Selby PJ; Trejdosiewicz LK; Southgate J
    J Cell Sci; 2004 Apr; 117(Pt 10):2029-36. PubMed ID: 15054105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JTP-426467 acts as a selective antagonist for peroxisome proliferator-activated receptor gamma in vitro and in vivo.
    Nishiu J; Ito M; Ishida Y; Kakutani M; Shibata T; Matsushita M; Shindo M
    Diabetes Obes Metab; 2006 Sep; 8(5):508-16. PubMed ID: 16918585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells.
    Choi SS; Cha BY; Lee YS; Yonezawa T; Teruya T; Nagai K; Woo JT
    Life Sci; 2009 Jun; 84(25-26):908-14. PubMed ID: 19376135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.